Ani Pharmaceuticals reported $-19195000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US $ -18137000 15.51M
Aurora Cannabis Inc ACB:CN C$ -86814000 23.72M
Canopy Growth Corp WEED:CN -114437000 194.91M
Depomed DEPO:US $ 12.09M 1.51M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Hikma Pharmaceutical HIK:LN 256M 23M
Knight Therapeutics Inc GUD:CN C$ 2.34M 2.65M
Lannett LCI:US $ -23942000 3.64M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NVS:US 3.32B 176M
Omeros OMER:US $ -37438000 2.39M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Sun Pharmaceuticals SUNP:IN 21.51B 5.28B
Teva Pharmaceutical TEVA:IT 734M 55M
Teva Pharmaceutical Industries TEVA:US 734M 55M